Canada Pension Plan Investment Board
PHAT icon

Canada Pension Plan Investment Board’s Phathom Pharmaceuticals PHAT Stock Holding History

Canada Pension Plan Investment Board’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,600
Closed -$76.3K – 1929
2025
Q4 		$76.3K Buy
4,600
+500
+12% +$7.14K ﹤0.01% 1851
2025
Q3 		$48.3K Buy
+4,100
New +$42.3K ﹤0.01% 1259
2025
Q1 		– Sell
-15,400
Closed -$125K – 1438
2024
Q4 		$125K Buy
+15,400
New +$191K ﹤0.01% 1224
2021
Q2 		– Sell
-20,000
Closed -$751K – 1309
2021
Q1 		$751K Buy
+20,000
New +$837K ﹤0.01% 1034

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Canada Pension Plan Investment Board's PHAT Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of Phathom Pharmaceuticals (PHAT) in Q1 2026, closing a stake of 4,600 shares — an estimated $76.3K sold.

Canada Pension Plan Investment Board first reported a position in PHAT in Q1 2021 and held it in 4 quarters. The position peaked at $751K in Q1 2021. 174 funds tracked by Wall St. Rank hold PHAT as of Q1 2026.

  • Canada Pension Plan Investment Board reported no remaining Phathom Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 4,600 Phathom Pharmaceuticals shares in Q1 2026, an estimated $76.3K.
  • Canada Pension Plan Investment Board first reported a position in Phathom Pharmaceuticals in Q1 2021 and held it in 4 quarters.
  • Canada Pension Plan Investment Board's Phathom Pharmaceuticals position peaked at $751K in Q1 2021.
  • 174 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.